M
MedAnnex
- Business Model
- B2B
- Total Funding
- $13.8M
- Last Round
- $13.8M Series BAug 2019
- Rounds
- 1
About
Clinical-stage biotech targeting annexin-A1 to develop treatments for cancers and autoimmune diseases.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
$13.8M
Aug 2019
Investors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
Simtra BioPharma Solutions
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Bloomington, United States1001–5000Biotech, Contract Manufacturing
Private Equity·$4.3B·Oct 2023
Isomorphic Labs
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
London, United Kingdom201–500Artificial Intelligence, Biotech
Venture Unknown·$3.2B·May 2026
inVentiv HealthAcquired
Biopharmaceutical services company
United States5001–10000Biotech, Healthcare
Private Equity·$3.0B·May 2017
WC
Warner ChilcottAcquired
Specialty pharmaceutical company
Rockaway, United States1001–5000Biotech, Healthcare
Private Equity·$3.0B·Jan 2004
Impossible Foods
Food technology company creating plant-based meat and dairy products that replicate the taste and...
Redwood City, United States501–1000Agtech, Biotech
Series G Plus·$2.4B·Nov 2021
AsymchemIPO
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Tianjin, China5001–10000Healthcare, Biotech
Private Equity·$2.3B·Feb 2020